共 50 条
- [32] Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 216 (02): : 151 - 165
- [38] Biomarkers and surrogate end points in clinical trials of tuberculosis treatment - Reply to Davies et al. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (04): : 649 - 650
- [39] SURROGATE END-POINTS IN CLINICAL-TRIALS - GETTING CLOSER TO IDENTIFYING MARKERS FOR SURVIVAL IN AIDS BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6768): : 63 - 64
- [40] Impact of Using the 2021 CKD-EPI Creatinine Equation on Clinical and Surrogate End Points in Trials JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 855 - 856